How did Moody's downgrade affect U.S. markets?
What impact will 23andMe sale have on genetic data privacy?
Why is Canada Post facing a potential postal strike?
How will Trump's tariffs influence U.S. housing market?
Why is JPMorgan allowing clients to buy Bitcoin now?
What caused the recent dip in Tesla's stock price?
How is AI changing job roles according to Indeed CEO?
Why are mortgage rates rising above 7%?
How will EU-UK post-Brexit reset affect trade?
GoodRx Offers Value Proposition As Pharmacy Costs Shifts To Consumers: Analyst
benzinga.com/general/health-care/25/05/45502299/goodrx-offers-value-proposition-as-pharmacy-costs-shifts-to-consumers-analyst
JP Morgan analyst Lisa C. Gill revised her 2025 outlook on GoodRx Holdings (NASDAQ:GDRX) following the company’s first-quarter earnings. Gill reaffirmed an Overweight rating on the stock and maintained her $7 price forecast.
The company reported first-quarter 2025 revenue of $203 million…
This story appeared on benzinga.com, 2025-05-19 18:14:46.